Αποτελέσματα Αναζήτησης
BILL NUMBER: S5299A SPONSOR: RIVERA TITLE OF BILL: An act to amend the insurance law, in relation to calculating an insured individual's overall contribution to any out-of-pocket maximum or any cost-sharing requirement PURPOSE OR GENERAL IDEA OF BILL: Requires insurance companies or pharmacy benefit managers to apply price reduction instruments ...
6 Ιουλ 2022 · During the 2022 session, the New York Assembly and Senate passed a copay accumulator ban bill that will ensure all cost-sharing by or on behalf of patients counts towards meeting their deductible and annual out-of-pocket limits (S5229A/A1741-A); and a bill that redefines the term “clinical peer reviewer” to ensure that health plans only use ...
7 Σεπ 2022 · The governors of New York and Delaware have co-pay accumulator ban bills on their desks awaiting signature. And other states legislatures have signaled they will consider the issue in upcoming sessions.
Governor Kathy Hochul’s call to ban copayments for life-saving insulin represents a marvelous step forward in consumer cost-saving and health equity that puts New York at the vanguard of drug-cost control legislation.
8 Ιουν 2021 · The bill, commonly referred to as the Copay Accumulator bill (S5299 Rivera/A1741 Gottfried), will help patients struggling to pay for their medication. While the legislation passed the Senate earlier this year, the bill has not received a vote in the Assembly.
25 Ιαν 2022 · When a bill ages or receives readings—which is required by the New York State Constitution—it is essentially giving other senators and members of the Assembly time (three legislative days to be exact) to see and review the bill before it can be brought up in the chamber for a vote.
22 Απρ 2024 · New York State lawmakers have eliminated the co-pay for insulin purchases statewide. This makes the Empire State the first in the nation to do so, according to the American Diabetes Association.
